Compare FTW & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTW | ARCT |
|---|---|---|
| Founded | N/A | 2013 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.8M | 526.5M |
| IPO Year | 2024 | N/A |
| Metric | FTW | ARCT |
|---|---|---|
| Price | $10.44 | $6.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.67 |
| AVG Volume (30 Days) | N/A | ★ 983.0K |
| Earning Date | N/A | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $5.85 |
| 52 Week High | N/A | $24.17 |
| Indicator | FTW | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 30.94 |
| Support Level | N/A | $5.85 |
| Resistance Level | N/A | $6.49 |
| Average True Range (ATR) | 0.00 | 0.47 |
| MACD | 0.00 | 0.32 |
| Stochastic Oscillator | 0.00 | 26.16 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.